Correction: Risk of developing checkpoint immune pneumonitis and its effect on overall survival in non-small cell lung cancer patients previously treated with radiotherapy

Key Points

• Overall survival is influenced by the risk of checkpoint immune pneumonitis in non-small cell lung cancer patients.
• The article provides a correction to previously reported findings regarding patient outcomes.
• Assessment of overall survival metrics indicates important implications for patient treatment strategies.
• Understanding risk factors may enhance treatment planning for lung cancer therapies.